| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |